Capstone Wealth Management Group (Pennsylvania)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Buy
638
+4
+0.6% +$1.43K 0.09% 90
2025
Q4
$207K Buy
+634
New +$201K 0.09% 81
2023
Q2
Sell
-898
Closed -$217K 57
2023
Q1
$217K Sell
898
-146
-14% -$35.8K 0.24% 52
2022
Q4
$274K Sell
1,044
-69
-6% -$18.5K 0.3% 53
2022
Q3
$251K Sell
1,113
-95
-8% -$23K 0.32% 51
2022
Q2
$294K Sell
1,208
-41
-3% -$10K 0.35% 49
2022
Q1
$302K Sell
1,249
-22
-2% -$5.05K 0.3% 54
2021
Q4
$286K Buy
+1,271
New +$268K 0.23% 68

Other funds holding AMGN

Capstone Wealth Management Group (Pennsylvania)'s AMGN Position: Q1 2026 in Review

Capstone Wealth Management Group (Pennsylvania) increased its Amgen (AMGN) stake by 0.63% in Q1 2026, buying an estimated $1.43K and bringing the position to 638 shares worth $224K. The position accounts for 0.09% of the portfolio, ranked #90.

Capstone Wealth Management Group (Pennsylvania) first reported a position in AMGN in Q4 2021 and has held it in 8 quarters since. The position peaked at $302K in Q1 2022. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capstone Wealth Management Group (Pennsylvania) held 638 shares of Amgen worth $224K as of Q1 2026.
  • Capstone Wealth Management Group (Pennsylvania) bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.09% of Capstone Wealth Management Group (Pennsylvania)'s portfolio in Q1 2026, its #90 holding.
  • Capstone Wealth Management Group (Pennsylvania) first reported a position in Amgen in Q4 2021 and has held it in 8 quarters since.
  • Capstone Wealth Management Group (Pennsylvania)'s Amgen position peaked at $302K in Q1 2022.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capstone Wealth Management Group (Pennsylvania)'s 13F filing for Q1 2026, filed 29 Apr 2026.